Neyns B - Search Results

1

Temozolomide dosing regimens for glioma patients.

Strik HM, Marosi C, Kaina B, Neyns B. Strik HM, et al. Among authors: neyns b. Curr Neurol Neurosci Rep. 2012 Jun;12(3):286-93. doi: 10.1007/s11910-012-0262-y. Curr Neurol Neurosci Rep. 2012. PMID: 22437507 Review.

2

The role of cytotoxic drugs in the treatment of central nervous system gliomas.

Neyns B, D'haeseleer M, Rogiers A, Van de Cauter J, Chaskis C, Michotte A, Strik H. Neyns B, et al. Acta Neurol Belg. 2010 Mar;110(1):1-14. Acta Neurol Belg. 2010. PMID: 20514922 Review.

3

Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations.

Chaskis C, Neyns B, Michotte A, De Ridder M, Everaert H. Chaskis C, et al. Among authors: neyns b. Surg Neurol. 2009 Oct;72(4):423-8. doi: 10.1016/j.surneu.2008.09.023. Epub 2009 Jan 15. Surg Neurol. 2009. PMID: 19150114

4

Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.

Neyns B, Tosoni A, Hwu WJ, Reardon DA. Neyns B, et al. Cancer. 2010 Jun 15;116(12):2868-77. doi: 10.1002/cncr.25035. Cancer. 2010. PMID: 20564393 Free article. Review.

5

Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma.

Duerinck J, Du Four S, Sander W, Van Binst AM, Everaert H, Michotte A, Hau P, Neyns B. Duerinck J, et al. Among authors: neyns b. Anticancer Res. 2015 Oct;35(10):5551-7. Anticancer Res. 2015. PMID: 26408725 Clinical Trial.

6

Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium.

Everaert E, Neyns B, Joosens E, Strauven T, Branle F, Menten J. Everaert E, et al. Among authors: neyns b. J Neurooncol. 2004 Oct;70(1):37-48. doi: 10.1023/b:neon.0000040809.97943.c0. J Neurooncol. 2004. PMID: 15527106

7

The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.

Neyns B, Sadones J, Chaskis C, De Ridder M, Keyaerts M, Veld PI, Michotte A. Neyns B, et al. Acta Neurol Belg. 2005 Sep;105(3):137-43. Acta Neurol Belg. 2005. PMID: 16255151 Review.

8

A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma.

Neyns B, Chaskis C, Joosens E, Menten J, D'Hondt L, Branle F, Sadones J, Michotte A. Neyns B, et al. Cancer Invest. 2008 Apr-May;26(3):269-77. doi: 10.1080/07357900701708393. Cancer Invest. 2008. PMID: 18317968 Clinical Trial.

9

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.

Stupp R, Hegi ME, Neyns B, Goldbrunner R, Schlegel U, Clement PM, Grabenbauer GG, Ochsenbein AF, Simon M, Dietrich PY, Pietsch T, Hicking C, Tonn JC, Diserens AC, Pica A, Hermisson M, Krueger S, Picard M, Weller M. Stupp R, et al. Among authors: neyns b. J Clin Oncol. 2010 Jun 1;28(16):2712-8. doi: 10.1200/JCO.2009.26.6650. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439646 Free article. Clinical Trial.

10

Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.

Neyns B, Cordera S, Joosens E, Pouratian N. Neyns B, et al. J Clin Oncol. 2008 Sep 20;26(27):4518-9. doi: 10.1200/JCO.2008.18.8177. J Clin Oncol. 2008. PMID: 18802168 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters